Iowa HF14 allows for the lawful prescription, distribution, and marketing of crystalline polymorph psilocybin upon its rescheduling by the FDA.

Iowa HF14 amends the state's Substances Act to allow for the lawful prescription, distribution, and marketing of crystalline polymorph psilocybin, also known as COMP 360, once it is approved by the United States Food and Drug Administration (FDA) and rescheduled. Currently, possession of psilocybin carries penalties ranging from a serious misdemeanor to a class "B" felony. The bill specifies that upon FDA approval and rescheduling, the drug will be removed from the state's schedule I list and its new federal classification will be recognized.

Iowa HF14 allows for the lawful prescription, distribution, and marketing of crystalline polymorph psilocybin upon its rescheduling by the FDA.

Iowa HF14 amends the state's Substances Act to allow for the lawful prescription, distribution, and marketing of crystalline polymorph psilocybin, also known as COMP 360, once it is approved by the United States Food and Drug Administration (FDA) and rescheduled. Currently, possession of psilocybin carries penalties ranging from a serious misdemeanor to a class "B" felony. The bill specifies that upon FDA approval and rescheduling, the drug will be removed from the state's schedule I list and its new federal classification will be recognized.